Skip to main content
PMC home page
The EMBO Journal logoLink to The EMBO Journal
. 1999 Feb 15;18(4):822–832. doi: 10.1093/emboj/18.4.822

A single membrane-embedded negative charge is critical for recognizing positively charged drugs by the Escherichia coli multidrug resistance protein MdfA.

R Edgar 1, E Bibi 1
PMCID: PMC1171175  PMID: 10022825

Abstract

The nature of the broad substrate specificity phenomenon, as manifested by multidrug resistance proteins, is not yet understood. In the Escherichia coli multidrug transporter, MdfA, the hydrophobicity profile and PhoA fusion analysis have so far identified only one membrane-embedded charged amino acid residue (E26). In order to determine whether this negatively charged residue may play a role in multidrug recognition, we evaluated the expression and function of MdfA constructs mutated at this position. Replacing E26 with the positively charged residue lysine abolished the multidrug resistance activity against positively charged drugs, but retained chloramphenicol efflux and resistance. In contrast, when the negative charge was preserved in a mutant with aspartate instead of E26, chloramphenicol recognition and transport were drastically inhibited; however, the mutant exhibited almost wild-type multidrug resistance activity against lipophilic cations. These results suggest that although the negative charge at position 26 is not essential for active transport, it dictates the multidrug resistance character of MdfA. We show that such a negative charge is also found in other drug resistance transporters, and its possible significance regarding multidrug resistance is discussed.

Full Text

The Full Text of this article is available as a PDF (511.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bibi E., Béjà O. Membrane topology of multidrug resistance protein expressed in Escherichia coli. N-terminal domain. J Biol Chem. 1994 Aug 5;269(31):19910–19915. [PubMed] [Google Scholar]
  2. Bibi E., Gros P., Kaback H. R. Functional expression of mouse mdr1 in Escherichia coli. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9209–9213. doi: 10.1073/pnas.90.19.9209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bohn C., Bouloc P. The Escherichia coli cmlA gene encodes the multidrug efflux pump Cmr/MdfA and is responsible for isopropyl-beta-D-thiogalactopyranoside exclusion and spectinomycin sensitivity. J Bacteriol. 1998 Nov;180(22):6072–6075. doi: 10.1128/jb.180.22.6072-6075.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolhuis H., Molenaar D., Poelarends G., van Veen H. W., Poolman B., Driessen A. J., Konings W. N. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis. J Bacteriol. 1994 Nov;176(22):6957–6964. doi: 10.1128/jb.176.22.6957-6964.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bolhuis H., van Veen H. W., Brands J. R., Putman M., Poolman B., Driessen A. J., Konings W. N. Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP. J Biol Chem. 1996 Sep 27;271(39):24123–24128. doi: 10.1074/jbc.271.39.24123. [DOI] [PubMed] [Google Scholar]
  6. Brickman E., Beckwith J. Analysis of the regulation of Escherichia coli alkaline phosphatase synthesis using deletions and phi80 transducing phages. J Mol Biol. 1975 Aug 5;96(2):307–316. doi: 10.1016/0022-2836(75)90350-2. [DOI] [PubMed] [Google Scholar]
  7. Béjà O., Bibi E. Functional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5969–5974. doi: 10.1073/pnas.93.12.5969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Béjà O., Bibi E. Multidrug resistance protein (Mdr)-alkaline phosphatase hybrids in Escherichia coli suggest a major revision in the topology of the C-terminal half of Mdr. J Biol Chem. 1995 May 26;270(21):12351–12354. doi: 10.1074/jbc.270.21.12351. [DOI] [PubMed] [Google Scholar]
  9. Calamia J., Manoil C. Membrane protein spanning segments as export signals. J Mol Biol. 1992 Apr 5;224(3):539–543. doi: 10.1016/0022-2836(92)90542-r. [DOI] [PubMed] [Google Scholar]
  10. Consler T. G., Persson B. L., Jung H., Zen K. H., Jung K., Privé G. G., Verner G. E., Kaback H. R. Properties and purification of an active biotinylated lactose permease from Escherichia coli. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):6934–6938. doi: 10.1073/pnas.90.15.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cronan J. E., Jr Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins. J Biol Chem. 1990 Jun 25;265(18):10327–10333. [PubMed] [Google Scholar]
  12. Edgar R., Bibi E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J Bacteriol. 1997 Apr;179(7):2274–2280. doi: 10.1128/jb.179.7.2274-2280.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fralick J. A. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol. 1996 Oct;178(19):5803–5805. doi: 10.1128/jb.178.19.5803-5805.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gottesman M. M., Hrycyna C. A., Schoenlein P. V., Germann U. A., Pastan I. Genetic analysis of the multidrug transporter. Annu Rev Genet. 1995;29:607–649. doi: 10.1146/annurev.ge.29.120195.003135. [DOI] [PubMed] [Google Scholar]
  15. Gottesman M. M., Pastan I., Ambudkar S. V. P-glycoprotein and multidrug resistance. Curr Opin Genet Dev. 1996 Oct;6(5):610–617. doi: 10.1016/s0959-437x(96)80091-8. [DOI] [PubMed] [Google Scholar]
  16. Grinius L. L., Goldberg E. B. Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump. J Biol Chem. 1994 Nov 25;269(47):29998–30004. [PubMed] [Google Scholar]
  17. Grinius L., Dreguniene G., Goldberg E. B., Liao C. H., Projan S. J. A staphylococcal multidrug resistance gene product is a member of a new protein family. Plasmid. 1992 Mar;27(2):119–129. doi: 10.1016/0147-619x(92)90012-y. [DOI] [PubMed] [Google Scholar]
  18. Ho S. N., Hunt H. D., Horton R. M., Pullen J. K., Pease L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989 Apr 15;77(1):51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
  19. Kushner S. R., Nagaishi H., Templin A., Clark A. J. Genetic recombination in Escherichia coli: the role of exonuclease I. Proc Natl Acad Sci U S A. 1971 Apr;68(4):824–827. doi: 10.1073/pnas.68.4.824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  21. Levy D. Membrane proteins which exhibit multiple topological orientations. Essays Biochem. 1996;31:49–60. [PubMed] [Google Scholar]
  22. Levy S. B. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother. 1992 Apr;36(4):695–703. doi: 10.1128/aac.36.4.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lewis K. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem Sci. 1994 Mar;19(3):119–123. doi: 10.1016/0968-0004(94)90204-6. [DOI] [PubMed] [Google Scholar]
  24. Lewis K., Naroditskaya V., Ferrante A., Fokina I. Bacterial resistance to uncouplers. J Bioenerg Biomembr. 1994 Dec;26(6):639–646. doi: 10.1007/BF00831539. [DOI] [PubMed] [Google Scholar]
  25. Li X. Z., Ma D., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob Agents Chemother. 1994 Aug;38(8):1742–1752. doi: 10.1128/aac.38.8.1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Littlejohn T. G., Paulsen I. T., Gillespie M. T., Tennent J. M., Midgley M., Jones I. G., Purewal A. S., Skurray R. A. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett. 1992 Aug 15;74(2-3):259–265. doi: 10.1016/0378-1097(92)90439-u. [DOI] [PubMed] [Google Scholar]
  27. Loo T. W., Clarke D. M. Membrane topology of a cysteine-less mutant of human P-glycoprotein. J Biol Chem. 1995 Jan 13;270(2):843–848. doi: 10.1074/jbc.270.2.843. [DOI] [PubMed] [Google Scholar]
  28. Ma D., Cook D. N., Alberti M., Pon N. G., Nikaido H., Hearst J. E. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol. 1993 Oct;175(19):6299–6313. doi: 10.1128/jb.175.19.6299-6313.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ma D., Cook D. N., Hearst J. E., Nikaido H. Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol. 1994 Dec;2(12):489–493. doi: 10.1016/0966-842x(94)90654-8. [DOI] [PubMed] [Google Scholar]
  30. Manoil C., Beckwith J. TnphoA: a transposon probe for protein export signals. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8129–8133. doi: 10.1073/pnas.82.23.8129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Marger M. D., Saier M. H., Jr A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport. Trends Biochem Sci. 1993 Jan;18(1):13–20. doi: 10.1016/0968-0004(93)90081-w. [DOI] [PubMed] [Google Scholar]
  32. Mine T., Morita Y., Kataoka A., Mizushima T., Tsuchiya T. Evidence for chloramphenicol/H+ antiport in Cmr (MdfA) system of Escherichia coli and properties of the antiporter. J Biochem. 1998 Jul;124(1):187–193. doi: 10.1093/oxfordjournals.jbchem.a022078. [DOI] [PubMed] [Google Scholar]
  33. Neyfakh A. A. Natural functions of bacterial multidrug transporters. Trends Microbiol. 1997 Aug;5(8):309–313. doi: 10.1016/S0966-842X(97)01064-0. [DOI] [PubMed] [Google Scholar]
  34. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994 Apr 15;264(5157):382–388. doi: 10.1126/science.8153625. [DOI] [PubMed] [Google Scholar]
  35. Nilsen I. W., Bakke I., Vader A., Olsvik O., El-Gewely M. R. Isolation of cmr, a novel Escherichia coli chloramphenicol resistance gene encoding a putative efflux pump. J Bacteriol. 1996 Jun;178(11):3188–3193. doi: 10.1128/jb.178.11.3188-3193.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Okusu H., Ma D., Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol. 1996 Jan;178(1):306–308. doi: 10.1128/jb.178.1.306-308.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Paulsen I. T., Brown M. H., Littlejohn T. G., Mitchell B. A., Skurray R. A. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3630–3635. doi: 10.1073/pnas.93.8.3630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Paulsen I. T., Brown M. H., Skurray R. A. Proton-dependent multidrug efflux systems. Microbiol Rev. 1996 Dec;60(4):575–608. doi: 10.1128/mr.60.4.575-608.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Paulsen I. T., Skurray R. A., Tam R., Saier M. H., Jr, Turner R. J., Weiner J. H., Goldberg E. B., Grinius L. L. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol Microbiol. 1996 Mar;19(6):1167–1175. doi: 10.1111/j.1365-2958.1996.tb02462.x. [DOI] [PubMed] [Google Scholar]
  40. Paulsen I. T., Skurray R. A. Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes--an analysis. Gene. 1993 Feb 14;124(1):1–11. doi: 10.1016/0378-1119(93)90755-r. [DOI] [PubMed] [Google Scholar]
  41. Pinner E., Kotler Y., Padan E., Schuldiner S. Physiological role of nhaB, a specific Na+/H+ antiporter in Escherichia coli. J Biol Chem. 1993 Jan 25;268(3):1729–1734. [PubMed] [Google Scholar]
  42. Saier M. H., Jr, Tam R., Reizer A., Reizer J. Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport. Mol Microbiol. 1994 Mar;11(5):841–847. doi: 10.1111/j.1365-2958.1994.tb00362.x. [DOI] [PubMed] [Google Scholar]
  43. Schuldiner S., Lebendiker M., Yerushalmi H. EmrE, the smallest ion-coupled transporter, provides a unique paradigm for structure-function studies. J Exp Biol. 1997 Jan;200(Pt 2):335–341. doi: 10.1242/jeb.200.2.335. [DOI] [PubMed] [Google Scholar]
  44. van Veen H. W., Venema K., Bolhuis H., Oussenko I., Kok J., Poolman B., Driessen A. J., Konings W. N. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10668–10672. doi: 10.1073/pnas.93.20.10668. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES